Step Pharma to Present Phase 2 Dencatistat Data at ASH Meeting
Step Pharma says it will present data from its ongoing phase 2 trial of dencatistat in essential thrombocythaemia. The company describes this as the first clinical data from its ET programme; the supplied body is truncated before further details.